Cholecalciferol on Hemodialysis Patients

Summary

* Screening the prevalence of vitamin D deficiency among Egyptian hemodialysis patients on a single center (Ain Shams University hospital). * Assessing the effect of the native type of vitamin D (Cholecalciferol) on replenishing its deficiency via extra-renal vitamin D receptors (VDR), among Egyptian hemodialysis patients. * Assessing the effect of cholecalciferol on vascular calcification among Egyptian hemodialysis patients. * Assessing the effect of cholecalciferol on Blood pressure, parathyroid hormone.

Timeline

Start

2018-07-01

Primary completion

2018-09-15

Completion

2018-09-28

Publications

• Alshahawey M, El Borolossy R, El Wakeel L, Elsaid T, Sabri NA. The impact of cholecalciferol on markers of vascular calcification in hemodialysis patients: A randomized placebo controlled study. Nutr Metab Cardiovasc Dis. 2021 Feb 8;31(2):626-633. doi: 10.1016/j.numecd.2020.09.014. Epub 2020 Sep 21.

Drugs

Indications